IV、v级证据因为存在疗效的不确定性,无法作为推荐的依据。但是可以作为进一步研究的依据或假说,为未来的研究提供线索。
参考文献
1.GlasziouP,VandenbroucheJP,ChalmersI.Assessingthe
qualityofresearch.BMJ2004;328:39-41.
2.GRADEWorkingGroup,(tradingqualityofevidenceandstrengtho
frecommendations.BMJ2004;328;1490-1497.
3.英国国家卫生服务部评价与传播中心.http://www.york.ac,uk/crd.
4.英国循证医学中心.http://www.cebm,net/levels-of-evi-dence.asp.
5.NationalHealthandMedicalResearchCouncil.Aguidetothedevelopment,
implementationandevaluationofclinicalpracticeguidelines.CommonwealthofAustralia
1999.http://www.health,gov.au/nhmrc/publicat/synopses/cp30syn.htm.
6.TugwellP,MaxwellL,BuchbinderR,etal.CochraneMusculoskeletalGroup.Aboutthe
CochraneCollaboration[CochraneReviewGroups(CRGs)]2007*Lssue1.Art.No:MUSKEL.
7.WHO.GuidelinesforWHOGuidelines(AnnexB).E1P/GPE/EQC/2003.1.pi8.
Geneva,Switzerland.
8.DelaneyA,BagshawSM,FerlandA,etal.Asystematicevaluationofthequalityofmeta-
analysesinthecriticalcareliterature.CritCare2005,*9:R575-582.
9.EggerM,SmithGD,SchneiderM,elal.Biasinmeta-analysisdetectedbyasimple,
graphicaltest-BMJ1997;315:629-634.
10.WalachH,FaJkenbergT,FonneboV,etal.Circularinsteadofhierarchical:methodological
principlasfortheevaluationofcomplexinterventions.BMCMedResMethodoJ2006;246:29.
11.BoutronI,CiuittetL,EstellatC,etal.ReportingmethodsofWindinginrandomize
dtrialsassessingnonpharmacologicaltreatments.PloaMed2007;4(2)oe61.
12.JuJliardKNfCitkovitzC,McDanielD.Towardsamodelforplanningc
linicalresearchinorientalmedicine.Explore2007;3(2):118-128.
13.BellomoR,BagshawSM.Evidence-basedmedicine:
classifyingtheevidencefromclinicaltrials-theneedtoconsiderother
dimensions.CritiCare2006;10^232-239.